Mark L. Watson

Mark Watson is currently the Chief Operating Officer at Guardian Research Network, with over 10 years of experience in the pharmaceutical industry. Prior to this, Mark founded Grace Biosciences to provide easy and affordable personalized medicine. Mark previously held leadership roles at Merck and GlaxoSmithKline, focusing on clinical development and biomarker projects. Mark has a strong scientific and technical background in molecular biology and statistical approaches, with a particular emphasis on theranostic development in clinical trials. Mark's education includes a Doctor of Medicine and Ph.D. in Medicine and Genetics from Duke University.